Lgc Clinical Diagnostics
UnclaimedIn-Vitro Diagnostic Substance ManufacturingMilford, MA
Founded
1984
Primary NAICS
325413
CAGE code
3Y6A3
Federal awards
$424.2K
Classification
This U.S. industry comprises establishments primarily engaged in manufacturing in-vitro (i.e., not taken internally) diagnostic substances, such as chemical, biological, or radioactive substances. The substances are used for diagnostic tests that are performed in test tubes, petri dishes, machines, and other diagnostic test-type devices.
- Manufacturing32
- Chemical Manufacturing325
- Pharmaceutical and Medicine Manufacturing32541
- In-Vitro Diagnostic Substance Manufacturing325413
Capabilities
Biological Product (except Diagnostic) Manufacturing
Federal awards
| Year | Agency | Obligated | Actions |
|---|---|---|---|
| 2026 | Department of Veterans Affairs | $73,974 | 1 |
| 2026 | Department of Health and Human Services | $43,810 | 1 |
| 2025 | Department of Health and Human Services | $44,811 | 5 |
| 2025 | Department of Defense | $15,685 | 1 |
| 2024 | Department of Defense | $31,369 | 1 |
| 2024 | Department of Justice | $15,408 | 3 |
| 2024 | Department of Health and Human Services | -$105 | 3 |
| 2023 | Department of Health and Human Services | $144,890 | 7 |
| 2023 | Department of Defense | $25,538 | 1 |
| 2022 | Department of Health and Human Services | $41,758 | 5 |
| 2022 | Department of Defense | $2,647 | 2 |
| 2022 | Department of Veterans Affairs | -$15,586 | 1 |